Small cap pharmaceutical stock Adamas Pharmaceuticals Inc (NASDAQ: ADMS) is thefourteenth most shorted stock on theNASDAQ with short interest of 40.18% according to Highshortinterest.com. Adamas Pharmaceuticals portfolio includes: GOCOVRITM (amantadine) extended release capsules (previously ADS-5
Led by the largest biotech IPO since June 2015, six companies raised $827 million this past week. Biotech Denali Therapeutics raised $250 million, making it the largest biotech IPO of the year by both deal size and market cap. The week also included pricings from a cancer biotech, a medical diagnostics company, a California bank, a payday lender and a SPAC. No companies priced above the midpoint.
As the end of the year nears, companies will start to report their end of the year numbers giving investors the opportunity to find value for their portfolios in 2017. Earlier this week, Nordson Corporation (NASDAQ:NDSN) released its numbers for the fourth quarter of its 2016 fiscal year. The machinery company, with market capitalization of just under $6.00 billion, specializes in a variety of manufacturing....More>>>
At $257,200.00 a share, investing in Berkshire Hathaway Inc. (NYSE: BRK.A) is simply not an option for most retail investors like us. But the nearly 50 other “Warren Buffett stocks” that Berkshire invests in come at a much lower price point.
While we at Money Morning don’t recommend all of Warren Buffett’s stock picks for retail investors, our experts do like....More>>>
The Federal Reserve raised its target of the federal-funds rate, the interest rate banks charge each other for overnight loans, by a quarter point to a range of 0.75% to 1%, and thats great news for Warren Buffetts Berkshire Hathaway (BRK.B) and its shareholders. As a bondholder, owner of insurance companies and an investor in big banks, Berkshire profits from rising interest rates in a number....More>>>
The so-called smart money on Wall Street sold Burger King in 2010 for $3.3 billion, minting over a billion dollars in profits and a five-fold gain for exiting investors including Bain Capital, TPG and Goldman Sachs. It was a whopper deal that left analysts scratching their heads as to how the buyer would get its money back.
A little over six years later, Burger King’s new owners have....More>>>
Dunkin' Brands Group(NASDAQ:DNKN) reports its second-quarter 2018 results next week on July 26.The quick-service restaurant chain has chalked up a stock price return of 35% over the last 12 months, due in part to investors' confidence in its strategy of investing in franchisee growth.
Prudential Financial Inc. decreased its stake in L3 Technologies (NYSE:LLL) by 20.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 87,847 shares of the aerospace company’s s
As promised, natural gas pipeline giant Kinder Morgan (NYSE:KMI) returned to growth mode in 2018. Overall, the company hauled in $1.247 billion ($0.56 per share) of distributable cash flow during the first quarter, which was 3% higher than the year-ago period, and beat its forecast.
Orange (EPA:ORA) has been assigned a €20.00 ($24.69) price target by equities researchers at Barclays in a research report issued to clients and investors on Monday. The firm currently has a “buy” rating on the stock. Barclays’ price target indicates a potential upside of